Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,931,000 | -1,301,000 | 79,000 | 8,362,000 | 6,897,000 |
| Depreciation Amortization | 378,000 | 141,000 | 61,000 | 379,000 | 303,000 |
| Income taxes - deferred | 934,000 | -530,000 | -310,000 | N/A | -473,000 |
| Accounts receivable | -481,000 | 1,153,000 | 272,000 | 1,790,000 | 480,000 |
| Accounts payable and accrued liabilities | -8,000 | -187,000 | -117,000 | 240,000 | 89,000 |
| Other Working Capital | -388,000 | -570,000 | -1,144,000 | -4,014,000 | -3,608,000 |
| Other Operating Activity | 756,000 | -846,000 | -66,000 | -1,776,000 | -369,000 |
| Operating Cash Flow | $-3,740,000 | $-2,140,000 | $-1,225,000 | $4,981,000 | $3,319,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -487,000 | -347,000 | -113,000 | -400,000 | -308,000 |
| Net Acquisitions | -85,000 | -85,000 | -85,000 | N/A | N/A |
| Purchase Of Investment | -2,120,000 | -1,304,000 | -1,108,000 | -11,475,000 | -8,960,000 |
| Sale Of Investment | 7,436,000 | 5,691,000 | 3,317,000 | 6,699,000 | 5,140,000 |
| Investing Cash Flow | $4,744,000 | $3,955,000 | $2,011,000 | $-5,176,000 | $-4,128,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,000 | 25,000 | 9,000 | 65,000 | 40,000 |
| Common Stock Repurchased | -1,153,000 | -1,154,000 | -526,000 | -3,329,000 | -2,927,000 |
| Other Financing Activity | -146,000 | -81,000 | -25,000 | -184,000 | -123,000 |
| Financing Cash Flow | $-1,268,000 | $-1,210,000 | $-542,000 | $-3,448,000 | $-3,010,000 |
| Beginning Cash Position | 3,217,000 | 3,217,000 | 3,217,000 | 6,860,000 | 6,860,000 |
| End Cash Position | 2,953,000 | 3,822,000 | 3,461,000 | 3,217,000 | 3,041,000 |
| Net Cash Flow | $-264,000 | $605,000 | $244,000 | $-3,643,000 | $-3,819,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,740,000 | -2,140,000 | -1,225,000 | 4,981,000 | 3,319,000 |
| Capital Expenditure | -487,000 | -347,000 | -113,000 | -400,000 | -308,000 |
| Free Cash Flow | -4,227,000 | -2,487,000 | -1,338,000 | 4,581,000 | 3,011,000 |